235 related articles for article (PubMed ID: 30185548)
1. Dual Inhibition of DNA and Histone Methyltransferases Increases Viral Mimicry in Ovarian Cancer Cells.
Liu M; Thomas SL; DeWitt AK; Zhou W; Madaj ZB; Ohtani H; Baylin SB; Liang G; Jones PA
Cancer Res; 2018 Oct; 78(20):5754-5766. PubMed ID: 30185548
[TBL] [Abstract][Full Text] [Related]
2. 5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.
Wozniak RJ; Klimecki WT; Lau SS; Feinstein Y; Futscher BW
Oncogene; 2007 Jan; 26(1):77-90. PubMed ID: 16799634
[TBL] [Abstract][Full Text] [Related]
3. [5-aza-2'-deoxycytidine induces changes of histone H3-lysine 9 methylation in bladder tumor cells].
Yang N; Li Z
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2295-8. PubMed ID: 19087683
[TBL] [Abstract][Full Text] [Related]
4. Ethanol induced acetylation of histone at G9a exon1 and G9a-mediated histone H3 dimethylation leads to neurodegeneration in neonatal mice.
Subbanna S; Nagre NN; Shivakumar M; Umapathy NS; Psychoyos D; Basavarajappa BS
Neuroscience; 2014 Jan; 258():422-32. PubMed ID: 24300108
[TBL] [Abstract][Full Text] [Related]
5. Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells.
Han H; Yang X; Pandiyan K; Liang G
PLoS One; 2013; 8(9):e75136. PubMed ID: 24040395
[TBL] [Abstract][Full Text] [Related]
6. DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells.
Meng CF; Su B; Li W
Mol Med Rep; 2011; 4(6):1273-8. PubMed ID: 21850374
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation.
Momparler RL; Idaghdour Y; Marquez VE; Momparler LF
Leuk Res; 2012 Aug; 36(8):1049-54. PubMed ID: 22472464
[TBL] [Abstract][Full Text] [Related]
8. Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.
Yokoyama M; Chiba T; Zen Y; Oshima M; Kusakabe Y; Noguchi Y; Yuki K; Koide S; Tara S; Saraya A; Aoyama K; Mimura N; Miyagi S; Inoue M; Wakamatsu T; Saito T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Yokosuka O; Iwama A
Oncotarget; 2017 Mar; 8(13):21315-21326. PubMed ID: 28423509
[TBL] [Abstract][Full Text] [Related]
9. Vitamin C increases viral mimicry induced by 5-aza-2'-deoxycytidine.
Liu M; Ohtani H; Zhou W; Ørskov AD; Charlet J; Zhang YW; Shen H; Baylin SB; Liang G; Grønbæk K; Jones PA
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10238-44. PubMed ID: 27573823
[TBL] [Abstract][Full Text] [Related]
10. Switching roles for DNA and histone methylation depend on evolutionary ages of human endogenous retroviruses.
Ohtani H; Liu M; Zhou W; Liang G; Jones PA
Genome Res; 2018 Aug; 28(8):1147-1157. PubMed ID: 29970451
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'-deoxycytidine treatment.
Egger G; Aparicio AM; Escobar SG; Jones PA
Cancer Res; 2007 Jan; 67(1):346-53. PubMed ID: 17210717
[TBL] [Abstract][Full Text] [Related]
12. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells.
Chen H; Yan Y; Davidson TL; Shinkai Y; Costa M
Cancer Res; 2006 Sep; 66(18):9009-16. PubMed ID: 16982742
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression.
Natoli M; Gallon J; Lu H; Amgheib A; Pinato DJ; Mauri FA; Marafioti T; Akarca AU; Ullmo I; Ip J; Aboagye EO; Brown R; Karadimitris A; Ghaem-Maghami S
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33436485
[TBL] [Abstract][Full Text] [Related]
16. The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry.
Zhao H; Ning S; Nolley R; Scicinski J; Oronsky B; Knox SJ; Peehl DM
Clin Epigenetics; 2017; 9():4. PubMed ID: 28149332
[TBL] [Abstract][Full Text] [Related]
17. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.
Hua KT; Wang MY; Chen MW; Wei LH; Chen CK; Ko CH; Jeng YM; Sung PL; Jan YH; Hsiao M; Kuo ML; Yen ML
Mol Cancer; 2014 Aug; 13():189. PubMed ID: 25115793
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.
Stone ML; Chiappinelli KB; Li H; Murphy LM; Travers ME; Topper MJ; Mathios D; Lim M; Shih IM; Wang TL; Hung CF; Bhargava V; Wiehagen KR; Cowley GS; Bachman KE; Strick R; Strissel PL; Baylin SB; Zahnow CA
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10981-E10990. PubMed ID: 29203668
[TBL] [Abstract][Full Text] [Related]
19. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
20. Antineoplastic action of 5-aza-2'-deoxycytidine and phenylbutyrate on human lung carcinoma cells.
Boivin AJ; Momparler LF; Hurtubise A; Momparler RL
Anticancer Drugs; 2002 Sep; 13(8):869-74. PubMed ID: 12394273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]